These stocks are gapping in today's session
BioVie Inc BIVI
$1.52
▲ +6.29%
(+$0.09)
⬆️ Above Yest. High
🎈 Low Float
Open
$1.45
Prev Close
$1.43
Day Range
$1.38 – $1.55
52W Range
$1.06 – $6.64
Market Cap
$11.46M
Beta
0.71
EPS (TTM)
$-4.32
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-01-14 |
| Shares Out. | 7,540,000 |
| Website | bioviepharma.com/ ↗ |
| Phone | 17758883162 |
| Employees | 13 |
| Net Income | -$5.3M |
| Total Assets | $17.5M |
| Total Liabilities | $1.9M |
| Equity | $15.6M |
About BioVie Inc
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
BioVie Inc is a publicly traded company under the ticker symbol BIVI on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)